N',N''-diacetylspermine: intermediate in polyamine catabolism [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 132679 |
| CHEBI ID | 178484 |
| MeSH ID | M0093934 |
| Synonym |
|---|
| n',n''-diacetylspermine |
| acetamide, n,n'-(1,4-butanediylbis(imino-3,1-propanediyl))bis-, dihydrochloride |
| 77928-71-3 |
| CHEBI:178484 |
| n-[3-[4-(3-acetamidopropylamino)butylamino]propyl]acetamide;dihydrochloride |
| diacetylspermine |
| n1,n12-diacetylspermine dihydrochloride |
| MS-25659 |
| n,n'-[butane-1,4-diylbis(azanediylpropane-3,1-diyl)]diethanimidic acid--hydrogen chloride (1/2) |
| DTXSID20999129 |
| n,n'-[1,4-butanediylbis(imino-3,1-propanediyl)]bis-acetamide, dihydrochloride |
| CS-0109683 |
| HY-113374A |
| n1,n12-diacetylspermine (dihydrochloride) |
| n1,n12-diacetylspermine (hydrochloride) |
| Class | Description |
|---|---|
| acetamides | Compounds with the general formula RNHC(=O)CH3. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (4.17) | 18.7374 |
| 1990's | 7 (14.58) | 18.2507 |
| 2000's | 17 (35.42) | 29.6817 |
| 2010's | 17 (35.42) | 24.3611 |
| 2020's | 5 (10.42) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (4.00%) | 5.53% |
| Reviews | 7 (14.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 41 (82.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| spermine | [no description available] | medium | 50 | 2 | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent |
| spermidine | [no description available] | medium | 12 | 0 | polyazaalkane; triamine | autophagy inducer; fundamental metabolite; geroprotector |
| malic acid | [no description available] | medium | 1 | 0 | 2-hydroxydicarboxylic acid; C4-dicarboxylic acid | food acidity regulator; fundamental metabolite |
| glycolic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid; primary alcohol | keratolytic drug; metabolite |
| homoarginine | [no description available] | medium | 1 | 0 | homoarginine; L-lysine derivative; non-proteinogenic L-alpha-amino acid | biomarker; EC 3.1.3.1 (alkaline phosphatase) inhibitor; human metabolite; rat metabolite; xenobiotic metabolite |
| proline | [no description available] | medium | 1 | 0 | amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid | algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
| orotic acid | [no description available] | medium | 1 | 0 | pyrimidinemonocarboxylic acid | Escherichia coli metabolite; metabolite; mouse metabolite |
| uridine | [no description available] | medium | 1 | 0 | uridines | drug metabolite; fundamental metabolite; human metabolite |
| n-methylproline | [no description available] | medium | 1 | 0 | L-alpha-amino acid zwitterion; L-proline derivative; tertiary amino compound | human metabolite; plant metabolite |
| niacinamide | [no description available] | medium | 1 | 0 | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
| nad | [no description available] | medium | 1 | 0 | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite |
| s-adenosylmethionine | [no description available] | medium | 1 | 0 | organic cation; sulfonium compound | coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
| colibactin | [no description available] | medium | 1 | 0 | 1,3-thiazoles; azaspiro compound; polyketide; pyrroline; secondary carboxamide | alkylating agent; carcinogenic agent; Escherichia coli metabolite; genotoxin |
| arginine | [no description available] | medium | 1 | 0 | arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical |
| ornithine | [no description available] | medium | 1 | 0 | non-proteinogenic L-alpha-amino acid; ornithine | algal metabolite; hepatoprotective agent; mouse metabolite |
| gold | [no description available] | medium | 1 | 0 | copper group element atom; elemental gold | |
| n'-acetylspermine | [no description available] | medium | 6 | 0 | acetamides; acetylspermine | human metabolite |
| putrescine | [no description available] | medium | 1 | 0 | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite |
| n(1)-acetylspermidine | [no description available] | medium | 2 | 0 | acetylspermidine | Escherichia coli metabolite; metabolite |
| n-(gamma-maleimidobutyryloxy)succinimide | [no description available] | medium | 2 | 0 | ||
| isoputreanine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| acetamide | [no description available] | low | 0 | 0 | acetamides; carboximidic acid; monocarboxylic acid amide; N-acylammonia | |
| melatonin | [no description available] | low | 0 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
| n-acetylserotonin | [no description available] | low | 0 | 0 | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist |
| acetanilide | [no description available] | low | 0 | 0 | acetamides; anilide | analgesic |
| 6-chloromelatonin | [no description available] | low | 0 | 0 | acetamides | |
| 6-hydroxymelatonin | [no description available] | low | 0 | 0 | acetamides; tryptamines | metabolite; mouse metabolite |
| acetaminophen | [no description available] | low | 0 | 0 | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
| acetarsol | [no description available] | low | 0 | 0 | acetamides; anilide | |
| 4-(acetylamino)benzeneacetic acid | [no description available] | low | 0 | 0 | acetamides; anilide | |
| diatrizoic acid | [no description available] | low | 0 | 0 | acetamides; benzoic acids; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
| ci 994 | [no description available] | low | 0 | 0 | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
| colchicine, (+-)-isomer | [no description available] | low | 0 | 0 | acetamides; alkaloid; aromatic ether; carbotricyclic compound | microtubule-destabilising agent; plant metabolite |
| gr 89696 | [no description available] | low | 0 | 0 | acetamides | |
| guanfacine | [no description available] | low | 0 | 0 | acetamides | |
| hexamethylene bisacetamide | [no description available] | low | 0 | 0 | acetamides | |
| acecainide | [no description available] | low | 0 | 0 | acetamides; benzamides | anti-arrhythmia drug |
| phenacemide | [no description available] | low | 0 | 0 | acetamides | |
| phenacetin | [no description available] | low | 0 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
| practolol | [no description available] | low | 0 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
| tropicamide | [no description available] | low | 0 | 0 | acetamides | |
| talactoferrin alfa | [no description available] | low | 0 | 0 | acetamides | |
| methacetin | [no description available] | low | 0 | 0 | acetamides; aromatic ether | |
| acedapsone | [no description available] | low | 0 | 0 | acetamides; anilide; secondary carboxamide; sulfone | antimalarial; antimicrobial drug |
| n-methylacetamide | [no description available] | low | 0 | 0 | acetamides; monocarboxylic acid amide | metabolite |
| acetopyrrothine | [no description available] | low | 0 | 0 | acetamides; dithiolopyrrolone antibiotic | angiogenesis inhibitor; antibacterial agent; antifungal agent; antineoplastic agent; bacterial metabolite; chelator; EC 2.7.7.6 (RNA polymerase) inhibitor; marine metabolite; protein synthesis inhibitor; toxin |
| phenylbutyramide | [no description available] | low | 0 | 0 | acetamides | |
| N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | acetamides; methoxybenzenes | |
| 4-methylacetanilide | [no description available] | low | 0 | 0 | acetamides; toluenes | |
| arsthinol | [no description available] | low | 0 | 0 | acetamides; anilide | |
| nithiamide | [no description available] | low | 0 | 0 | acetamides; aromatic amide | |
| 4'-(chloroacetyl)acetanilide | [no description available] | low | 0 | 0 | acetamides; alpha-chloroketone; aromatic ketone | |
| 4-chloroacetanilide | [no description available] | low | 0 | 0 | acetamides; monochlorobenzenes | |
| monoacetyldapsone | [no description available] | low | 0 | 0 | acetamides; anilide; secondary carboxamide; sulfone | |
| 2-hydroxyacetanilide | [no description available] | low | 0 | 0 | acetamides; phenols | anti-inflammatory agent; antineoplastic agent; antirheumatic drug; apoptosis inducer; platelet aggregation inhibitor; xenobiotic metabolite |
| 3-hydroxyacetanilide | [no description available] | low | 0 | 0 | acetamides; phenols | non-narcotic analgesic |
| n-ethylacetamide | [no description available] | low | 0 | 0 | acetamides | metabolite |
| ethyl n-alpha-acetyl-tyrosinate | [no description available] | low | 0 | 0 | acetamides; ethyl ester; L-tyrosine derivative; phenols | |
| 2-acetamidoethanethiol | [no description available] | low | 0 | 0 | acetamides | metabolite |
| n,n-diethylphenylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| trimethylcolchicinic acid methyl ether | [no description available] | low | 0 | 0 | acetamides; alkaloid; carbotricyclic compound | |
| dimethylacetamide | [no description available] | low | 0 | 0 | acetamides; monocarboxylic acid amide | human metabolite |
| 4-acetylaminofluorene | [no description available] | low | 0 | 0 | acetamides; fluorenes | mitogen |
| ioxitalamic acid | [no description available] | low | 0 | 0 | acetamides; benzoic acids; dicarboxylic acid monoamide; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
| lorcainide | [no description available] | low | 0 | 0 | acetamides | |
| bidisomide | [no description available] | low | 0 | 0 | acetamides | |
| n(4)-acetylsulfadiazine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| oseltamivir | [no description available] | low | 0 | 0 | acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic |
| 6-sulfatoxymelatonin | [no description available] | low | 0 | 0 | acetamides | |
| n-acetylaminoantipyrine | [no description available] | low | 0 | 0 | acetamides; pyrazoles | drug metabolite; marine xenobiotic metabolite |
| milnacipran | [no description available] | low | 0 | 0 | acetamides | |
| N(4)-acetylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; acetamides; sulfonamide | marine xenobiotic metabolite |
| disobutamide | [no description available] | low | 0 | 0 | acetamides | |
| glycolamide | [no description available] | low | 0 | 0 | acetamides | |
| n-acetylhistamine | [no description available] | low | 0 | 0 | acetamides; imidazoles | human metabolite |
| n-acetyltryptamine | [no description available] | low | 0 | 0 | acetamides; indoles | |
| acamprosate | [no description available] | low | 0 | 0 | acetamides; organosulfonic acid | environmental contaminant; neurotransmitter agent; xenobiotic |
| guanfacine hydrochloride | [no description available] | low | 0 | 0 | acetamides | geroprotector |
| epanolol | [no description available] | low | 0 | 0 | acetamides | |
| N-Acetylhomoveratrylamine | [no description available] | low | 0 | 0 | acetamides | |
| s20098 | [no description available] | low | 0 | 0 | acetamides | |
| acetaminophen sulfate ester | [no description available] | low | 0 | 0 | acetamides; aryl sulfate | drug metabolite |
| acetaminophen mercapturate | [no description available] | low | 0 | 0 | acetamides; organic sulfide; phenols; S-substituted N-acetyl-L-cysteine | drug metabolite; human urinary metabolite; rat metabolite |
| 4-(hydroxyphenyl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| n-acetyltryptophanamide | [no description available] | low | 0 | 0 | acetamides; L-tryptophan derivative; primary carboxamide; secondary carboxamide | |
| n-acetyldopamine | [no description available] | low | 0 | 0 | acetamides; catechols; N-(fatty acyl)-dopamine; secondary carboxamide | human urinary metabolite; marine metabolite |
| ethyl-3-(n-n-butyl-n-acetyl)aminopropionate | [no description available] | low | 0 | 0 | acetamides; ethyl ester; tertiary carboxamide | |
| n-acetylcytidine | [no description available] | low | 0 | 0 | acetamides; cytidines; secondary carboxamide | metabolite |
| 2-iodomelatonin | [no description available] | low | 0 | 0 | acetamides | |
| n-acetyltyramine | [no description available] | low | 0 | 0 | acetamides; tyramines | animal metabolite; Aspergillus metabolite; bacterial metabolite; marine metabolite; quorum sensing inhibitor |
| luzindole | [no description available] | low | 0 | 0 | acetamides; indoles | melatonin receptor antagonist |
| acetylphenylalanyl-prolyl-boroarginine | [no description available] | low | 0 | 0 | acetamides; C-terminal boronic acid peptide; guanidines | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor |
| bcx 1812 | [no description available] | low | 0 | 0 | 3-hydroxy monocarboxylic acid; acetamides; cyclopentanols; guanidines | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor |
| acetyltaurine | [no description available] | low | 0 | 0 | acetamides; organosulfonic acid | human blood serum metabolite; human urinary metabolite |
| milnacipran hydrochloride | [no description available] | low | 0 | 0 | acetamides | |
| n(4)-acetylsulfadimethoxine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| monoacetylcadaverine | [no description available] | low | 0 | 0 | acetamides; N-substituted cadaverine; primary amino compound; secondary carboxamide | human metabolite |
| N-hydroxy-2-phenylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-(1-phenylethyl)acetamide | [no description available] | low | 0 | 0 | acetamides; secondary carboxamide | |
| gamma-lumicolchicine | [no description available] | low | 0 | 0 | acetamides; alkaloid; carbotricyclic compound | |
| 1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | low | 0 | 0 | acetamides | |
| mr 16728 | [no description available] | low | 0 | 0 | acetamides | |
| linezolid | [no description available] | low | 0 | 0 | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor |
| ammodendrine | [no description available] | low | 0 | 0 | acetamides; N-acylpiperidine; piperidine alkaloid | plant metabolite; teratogenic agent |
| laninamivir | [no description available] | low | 0 | 0 | acetamides | |
| N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide | [no description available] | low | 0 | 0 | acetamides; piperidines; pyridines; sulfonamide | |
| 2-(4-methoxyphenyl)-N-(phenylmethyl)-N-propan-2-ylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[4-(4-morpholinylazo)phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[4-(5-bromo-2-thiophenyl)-2-thiazolyl]acetamide | [no description available] | low | 0 | 0 | acetamides; aromatic amide | |
| 1-(1-azepanyl)-2-(4-bromophenyl)ethanone | [no description available] | low | 0 | 0 | acetamides | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-(5-chloro-2-hydroxyphenyl)-2-(4-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[3-(methylthio)-1,2,4-thiadiazol-5-yl]-2-phenylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| 2-(3-acetamidophenoxy)-N-phenylacetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| 1-(4-methoxyphenyl)-N-(1,3,4-thiadiazol-2-yl)-1-cyclopentanecarboxamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| 1-[[2-(3-bromo-4-methoxyphenyl)-1-oxoethyl]amino]-3-phenylthiourea | [no description available] | low | 0 | 0 | acetamides | |
| 4-(2,4-dichlorophenyl)-2-[(1-oxo-2-phenylethyl)amino]-3-thiophenecarboxamide | [no description available] | low | 0 | 0 | acetamides | |
| 2-acetamido-5-propyl-3-thiophenecarboxamide | [no description available] | low | 0 | 0 | acetamides; aromatic amide | |
| 2-(4-methoxyphenyl)-N-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides | |
| 2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| 2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides | |
| 1-ethyl-3-[(1-oxo-2-phenylethyl)amino]thiourea | [no description available] | low | 0 | 0 | acetamides | |
| N-[4-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| 2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| 2-(4-chlorophenyl)-N-[4-(difluoromethylthio)phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides | |
| N-(4-acetamidophenyl)-2-[5-(1-piperidinylsulfonyl)-2-thiophenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[4-[(2-furanylmethylamino)-sulfanylidenemethyl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| acetylthiourea | [no description available] | low | 0 | 0 | acetamides; thioureas | |
| alpha-acetyllysine methyl ester | [no description available] | low | 0 | 0 | acetamides; alpha-amino acid ester; L-lysine derivative; methyl ester; primary amino compound | |
| 1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | low | 0 | 0 | acetamides | |
| N-(2-methoxyphenyl)-2-phenyl-2-(phenylthio)acetamide | [no description available] | low | 0 | 0 | acetamides | |
| ici 199441 | [no description available] | low | 0 | 0 | acetamides | |
| N-[4-[[2-(4-acetamidoanilino)-5-nitro-4-pyrimidinyl]amino]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| 1-[5-hydroxy-3-methyl-5-(3-pyridinyl)-4H-pyrazol-1-yl]-2-(4-methylphenyl)ethanone | [no description available] | low | 0 | 0 | acetamides | |
| 2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| CID 3191469 | [no description available] | low | 0 | 0 | acetamides; anilide | anticoronaviral agent |
| CID 3198732 | [no description available] | low | 0 | 0 | acetamides; anilide | anticoronaviral agent |
| 2-(4-ethoxyphenyl)-1-[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]ethanone | [no description available] | low | 0 | 0 | acetamides | |
| 5-methoxycarbonylamino-n-acetyltryptamine | [no description available] | low | 0 | 0 | acetamides | |
| 2-(4-chlorophenyl)-3-methyl-N-(2-thiazolyl)butanamide | [no description available] | low | 0 | 0 | acetamides | |
| N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| brl 52537 | [no description available] | low | 0 | 0 | acetamides | |
| 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer | [no description available] | low | 0 | 0 | acetamides | |
| levomilnacipran | [no description available] | low | 0 | 0 | acetamides | |
| andarine | [no description available] | low | 0 | 0 | acetamides; anilide | |
| ro-28-1675 | [no description available] | low | 0 | 0 | acetamides | |
| holomycin | [no description available] | low | 0 | 0 | acetamides; dithiolopyrrolone antibiotic | antibacterial agent; antineoplastic agent; bacterial metabolite; chelator; EC 2.7.7.6 (RNA polymerase) inhibitor; marine metabolite |
| N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| trametinib | [no description available] | low | 0 | 0 | acetamides; aromatic amine; cyclopropanes; organofluorine compound; organoiodine compound; pyridopyrimidine; ring assembly | anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector |
| n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine | [no description available] | low | 0 | 0 | acetamides | |
| 2-acetamidoglucal | [no description available] | low | 0 | 0 | acetamides; glycal derivative | metabolite |
| 3-[1-[[1-(4-methoxyphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | [no description available] | low | 0 | 0 | acetamides | |
| 3-[1-[[1-(4-methylphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | [no description available] | low | 0 | 0 | acetamides | |
| 3-[1-[oxo-(1-phenylcyclopropyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | [no description available] | low | 0 | 0 | acetamides | |
| 3-[1-[[1-(4-chlorophenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | [no description available] | low | 0 | 0 | acetamides | |
| n(alpha)-acetylfusarinines | [no description available] | low | 0 | 0 | 2,5-diketopiperazines; acetamides; carboxylic ester; homoallylic alcohol; hydroxamic acid; primary alcohol | siderophore |
| N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-5-bromo-2-furancarboxamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[(2S,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide | [no description available] | low | 0 | 0 | acetamides | |
| KOM70144 | [no description available] | low | 0 | 0 | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor |
| n-(2-(5-methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)ethyl)acetamide | [no description available] | low | 0 | 0 | acetamides; hydroxyindoles; tryptamines | antineoplastic agent; apoptosis inducer; plant metabolite |
| N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide | |
| N-[4-[2-(2-oxolanylmethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | acetamides; anilide |